Acrivastine and pseudoephedrine and Indacaterol and glycopyrrolate Inhalation
Determining the interaction of Acrivastine and pseudoephedrine and Indacaterol and glycopyrrolate Inhalation and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: acrivastine / pseudoephedrine
Brand name: Semprex-D
Synonyms: Acrivastine and Pseudoephedrine
Generic Name: glycopyrrolate / indacaterol
Brand name: Utibron Neohaler
Synonyms: Glycopyrrolate and indacaterol (inhalation), Indacaterol and Glycopyrrolate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Acrivastine and pseudoephedrine-Indacaterol inhalation
- Acrivastine and pseudoephedrine-Indacaterol Maleate
- Acrivastine and pseudoephedrine-Indapamide
- Acrivastine and pseudoephedrine-Inderal
- Acrivastine and pseudoephedrine-Inderal Intravenous
- Acrivastine and pseudoephedrine-Inderal LA
- Indacaterol and glycopyrrolate Inhalation-Actamin
- Indacaterol and glycopyrrolate Inhalation-Actamin Maximum Strength
- Indacaterol and glycopyrrolate Inhalation-Actemra
- Indacaterol and glycopyrrolate Inhalation-Actemra (Tocilizumab (Intravenous))
- Indacaterol and glycopyrrolate Inhalation-Actemra (Tocilizumab Auto-Injectors)
- Indacaterol and glycopyrrolate Inhalation-Actemra (Tocilizumab Prefilled Syringes)